The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125499243 12549924 3 F 20160627 20160727 20160712 20160803 EXP JP-AMGEN-JPNCT2016089520 AMGEN 68.00 YR E M Y 58.00000 KG 20160803 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125499243 12549924 1 PS denosumab DENOSUMAB 1 Subcutaneous 60 MG, Q3MO 300 MG 125320 60 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
125499243 12549924 2 SS denosumab DENOSUMAB 1 Subcutaneous 60 MG, Q3MO 300 MG 125320 60 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
125499243 12549924 3 SS RHEUMATREX METHOTREXATE SODIUM 1 Oral 10 MG, QWK 0 10 MG /wk
125499243 12549924 4 C FOLIAMIN FOLIC ACID 1 Oral 6 MG, QD 4962 MG 0 6 MG QD
125499243 12549924 5 C FOLIAMIN FOLIC ACID 1 4962 MG 0
125499243 12549924 6 C TSURUMERIN 2 Oral 10 MG, QD 0 10 MG QD
125499243 12549924 7 C REBAMIPIDE REBAMIPIDE 1 Oral 300 MG, QD 0 300 MG QD
125499243 12549924 8 C DENOTAS CALCIUM CARBONATECHOLECALCIFEROLMAGNESIUM CARBONATE 1 Oral 2 DF, QD 0 2 DF QD
125499243 12549924 9 C DENOTAS CALCIUM CARBONATECHOLECALCIFEROLMAGNESIUM CARBONATE 1 0
125499243 12549924 10 C LACTEC CALCIUM CHLORIDE ANHYDROUSPOTASSIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE 1 Intravenous drip 500 ML, Q3H 0 500 ML
125499243 12549924 11 C VITAMEDIN CYANOCOBALAMINPYRIDOXINE HYDROCHLORIDETHIAMINE 1 Intravenous drip 1 DF, BID 0 1 DF BID
125499243 12549924 12 C TAKEPRON LANSOPRAZOLE 1 Intravenous (not otherwise specified) 30 MG, BID 0 30 MG BID
125499243 12549924 13 C ISOTONIC SODIUM CHLORIDE SOLUTION SODIUM CHLORIDE 1 100 ML, UNK 0 20 ML BID
125499243 12549924 14 C BFLUID AMINO ACIDSDEXTROSEELECTROLYTES NOSVITAMINS 1 Intravenous drip 500 ML, QD 0 500 ML QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125499243 12549924 1 Rheumatoid arthritis
125499243 12549924 3 Rheumatoid arthritis
125499243 12549924 4 Prophylaxis
125499243 12549924 5 Adverse reaction
125499243 12549924 6 Myositis
125499243 12549924 7 Gastritis prophylaxis
125499243 12549924 8 Vitamin supplementation
125499243 12549924 9 Mineral supplementation
125499243 12549924 10 Fluid replacement
125499243 12549924 11 Fluid replacement
125499243 12549924 12 Abdominal discomfort
125499243 12549924 13 Gastrointestinal disorder
125499243 12549924 14 Fluid replacement

Outcome of event

Event ID CASEID OUTC COD
125499243 12549924 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125499243 12549924 Interstitial lung disease

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125499243 12549924 1 20141015 0
125499243 12549924 2 20151022 0
125499243 12549924 3 20140602 0
125499243 12549924 4 20140326 0
125499243 12549924 6 20131122 0
125499243 12549924 7 20131122 0
125499243 12549924 8 20140925 0
125499243 12549924 10 20160702 0
125499243 12549924 11 20160702 0
125499243 12549924 12 20160702 20160704 0
125499243 12549924 13 20160702 0
125499243 12549924 14 20160703 0